A randomized trial of ceftriaxone versus trimethoprim-sulfamethoxazole to prevent ventriculoperitoneal shunt infection

Journal of Microbiology, Immunology and Infection

Volumn 41, Issue 2, 2008, Pages 112-117

  Nejat, Farideh ^a   Tajik, Parvin ^a   Khashab, Mostafa El ^b   Kazmi, Syed Shuja ^a   Khotaei, Ghamar Taj ^c   Salahesh, Shahrzad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b CHILDREN S MEDICAL CENTER   (United States)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibiotic prophylaxis; Ceftriaxone; Meningitis; Trimethoprim sulfamethoxazole combination; Ventriculoperitoneal shunt

Indexed keywords

CEFTRIAXONE; COTRIMOXAZOLE;

ABSENCE OF SIDE EFFECTS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BRAIN AQUEDUCT STENOSIS; BRAIN VENTRICLE PERITONEUM SHUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FOLLOW UP; GENDER; HOSPITALIZATION; HUMAN; HYDROCEPHALUS; INFECTION PREVENTION; INFECTION RISK; LIQUORRHEA; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RASH; SHUNT INFECTION; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TREATMENT INDICATION; UNIVARIATE ANALYSIS;

ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MENINGITIS, BACTERIAL; POSTOPERATIVE COMPLICATIONS; SURGICAL WOUND INFECTION; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VENTRICULOPERITONEAL SHUNT;

EID: 48649108332     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Claus EB, Duncan C. Shunt infection. In: Winn HR, ed. Youman's neurological surgery. Vol. 3. 5th ed. Philadelphia: WB Saunders; 2003:3419-25.
2. Pople IK, Bayston R, Hayward RD. Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg. 1992;77:29-36.
3. Mottolese C, Grando J, Convert J, Abdoulrahman M, Le-lievre H, Vandenesch F, et al. Zero rate of shunt infection in the first postoperative year in children - dream or reality? Childs Nerv Syst. 2000;16:210-2.
4. Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg. 2001:94:195-201.
5. Rotim K, Miklic P, Palaldino J, Melada A, Marcikic M, Scap M. Reducing the incidence of infection in pediatric cerebrospinal fluid shunt operations. Childs Nerv Syst. 1997; 13; 584-7.
6. Mancao M, Miller C, Cochrane B, Hoff C, Sauter K, Weber E. Cerebrospinal fluid shunt infections in infants and children in Mobile, Alabama. Acta Paediatr. 1998;87:667-70.
7. Young RF, Lawner PM. Perioperative antibiotic prophylaxis for prevention of postoperative neurosurgical infections. A randomized clinical trial. J Neurosurg 1987;66: 701-5.
8. Wang KW, Chang WN, Shih TY, Huang CR, Tsai NW, Chang CS, et al. Infection of cerebrospinal fluid shunts: causative pathogens, clinical features, and outcomes. Jpn J Infect Dis. 2004;57:44-8.
9. Drake JM, Kestle JR, Tuli S. CSF shunts 50 years on-past, present and future. Childs Nerv Syst. 2000;16:800-4.
10. Sweetman SC. The complete drug reference. Vol. 1. 33rd ed. Chicago: Pharmaceutical Press; 2002:177-9,193-5.
11. Whitby M, Johnson BC, Atkinson RL, Stuart G. The comparative efficacy of intravenous cefotaxime and trimethoprim/ sulfamethoxazol in preventing infection after neurosurgery: A prospective, randomized study. Br J Neurosurg. 2000; 14: 13-8.
12. Odio C, McCracken GH Jr, Nelson JD. CSF shunt infections in pediatrics. A seven-year experience. Am J Dis Child. 1984;138:1103-8.
13. Schmidt K, Gjerris F, Osgaard O, Hvidberg EF, Kristiansen JE, Dahlerup B, et al. Antibiotic prophylaxis in cerebrospinal fluid shunting: a prospective randomized trial in 152 hydrocephalic patients. Neurosurgery. 1985;17:1-5.
14. Rieder MJ, Frewen TC, Del Maestro RF, Coyle A, Lovell S. The effect of cephalothin prophylaxis on postoperative ventriculoperitoneal shunt infections. CMAJ. 1987; 136: 935-8.
15. Zentner J, Gilsbach J, Felder T. Antibiotic prophylaxis in cerebrospinal fluid shunting: a prospective randomized trial in 129 patients. Neurosurg Rev. 1995;18:169-72.
16. Haines SJ, Taylor F. Prophylactic methicillin for shunt operations: effects on incidence of shunt malfunction and infection. Childs Brain. 1982;9:10-22.
17. Wang EE, Prober CG, Hendrick BE, Hoffman HJ, Humphreys RP. Prophylactic sulfamethoxazole and trimethoprim in ventriculoperitoneal shunt surgery. A double-blind, randomized, placebo-controlled trial. JAMA. 1984;251: 1174-7.
18. Djindjian M, Fevrier MJ, Otterbein G, Soussy JC. Oxacillin prophylaxis in cerebrospinal fluid shunt procedures: results of a randomized open study in 60 hydrocephalic patients. Surg Neurol. 1986;25:178-80.
19. Bayston R, Bannister C, Boston V, Burman R, Burns B, Cooke F, et al. A prospective randomised controlled trial of antimicrobial prophylaxis in hydrocephalus shunt surgery. Z Kinderchir. 1990;45(Suppl l):5-7.
20. Haines SJ, Walters BC. Antibiotic prophylaxis for cerebrospinal fluid shunts: a metanalysis. Neurosurgery. 1994;34: 87-92.
21. Piatt JH Jr, Carlson CV. A search for determinants of cerebrospinal fluid shunt survival: retrospective analysis of a 14-year institutional experience. Pediatr Neurosurg. 1993; 19:223-41; discussion 242.
22. Davis SE, Levy ML, McComb JG, Masri-Lavine L. Dose age or other factors influence the incidence of ventriculoperitoneal shunt infections? Pediatr Neurosug. 1999;30: 253-7.
23. Enger PØ, Svendsen F, Wester K. CSF shunt infections in children: experiences from a population-based study. Acta Neurochir (Wien). 2003;145:243-8.
24. Borgbjerg BM, Gjerris F, Albeck MJ, Børgesen SE. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien). 1995;136:1-7.
25. Kontny U, Höfling B, Gutjahr P, Voth D, Schwarz M, Schmitt HJ. CSF shunt infections in children. Infection. 1993;21:89-92.